Page last updated: 2024-10-30

mefenamic acid and Osteogenesis Imperfecta

mefenamic acid has been researched along with Osteogenesis Imperfecta in 1 studies

Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.

Osteogenesis Imperfecta: COLLAGEN DISEASES characterized by brittle, osteoporotic, and easily fractured bones. It may also present with blue sclerae, loose joints, and imperfect dentin formation. Most types are autosomal dominant and are associated with mutations in COLLAGEN TYPE I.

Research Excerpts

ExcerptRelevanceReference
"Mefenamic acid is a fenamate nonsteroidal anti-inflammatory (NSAI) drug, which is used for several years for pain management."1.51Central nervous system toxicity due to mefenamic acid. ( Çaylak, ST; Doğan, NÖ; Yılmaz, S, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doğan, NÖ1
Çaylak, ST1
Yılmaz, S1

Other Studies

1 other study available for mefenamic acid and Osteogenesis Imperfecta

ArticleYear
Central nervous system toxicity due to mefenamic acid.
    The American journal of emergency medicine, 2019, Volume: 37, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Emergency Service, Hospital; Female; Humans; Mefenam

2019